Search results
15 Life-Altering Moments In The Lives Of Cancer Survivors That Will Give You A New Perspective On...
BuzzFeed via Yahoo News· 4 days agoAnton Dobrea / Getty Images 9."I am 78 years old and at the age of 70, I was diagnosed with prostate...
This Weird Habit Is One of the Most Common Signs of Brain Cancer, According to Neurologists
Parade via Yahoo News· 5 days agoMina...tumors." But how? Even some of your habits may be a signal you have brain cancer. Dr. Lobbous...
The 10 Best Performing Stocks So Far In 2024
Forbes· 2 days agoThe stocks have been on a tear with year-to-date gains ranging from 387% to more than a jaw-dropping 1,100% (as of June 14’s market close). The stock market has been buoyant ...
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial -...
Benzinga· 5 days agoThe study did not meet the dual primary endpoints of improvement in overall survival (OS) versus...
Lantheus (LNTH) Gains 33.3% YTD: What's Driving the Stock?
Zacks· 6 days agoFree Report) witnessed strong momentum in the year-to-date period. Shares of the company have rallied 33.3% compared with 3.1% growth of the industry. With healthy fundamentals ...
AI Enhances Readability of Cancer Information for Patients
Medscape· 7 days agoChatGPT improved the readability of cancer-related information on patient-facing websites, without...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 5 days agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...
With iOnctura and Yellowstone, Syncona adds two cancer biotechs to growing portfolio
FierceBiotech· 3 days agoSyncona has added two up-and-coming cancer companies to its portfolio, ensuring the biotechs are armed with a combined total of over $100 million in series A and B funds.
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 3 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
IgG4-Related Disease Affects Men More Often, More Severely
Medscape· 4 days agoA recent study highlighted sex-based differences in manifestations of IgG4-related disease.